VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO 2021 | Breast cancer advances in 2021

Guy Jerusalem, MD, PhD, Domaine Universitaire du Sart Tilman, Liège, Belgium, shares exciting upcoming developments in the breast cancer field. Dr Jerusalem highlights antibody-drug conjugates (ADCs) and immunotherapies as major areas of interest where lots of promising data is expected in the coming years. Further research will clarify optimal targets for ADCs, as well as the best way to combine immunotherapies for maximal patient responses. This interview took place at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter